Valuation Metrics Signal Improved Price Attractiveness
Recent data reveals that Alufluoride’s price-to-earnings (P/E) ratio stands at 14.46, a level that is notably lower than many of its industry peers. This P/E multiple is complemented by a price-to-book value (P/BV) ratio of 2.84, which also suggests a more reasonable valuation compared to the sector’s average. The company’s enterprise value to EBITDA (EV/EBITDA) ratio of 7.65 further underscores its relative affordability, especially when contrasted with competitors such as Sanstar and Titan Biotech, whose EV/EBITDA ratios exceed 40 and 70 respectively.
These valuation improvements have prompted a downgrade in the company’s Mojo Grade from Buy to Hold as of 10 March 2026, reflecting a more cautious stance despite the attractive pricing. The Mojo Score currently stands at 61.0, indicating moderate confidence in the stock’s near-term prospects.
Peer Comparison Highlights Relative Value
When compared with its peers in the commodity chemicals sector, Alufluoride’s valuation appears compelling. For instance, Sanstar is classified as expensive with a P/E of 75.78 and an EV/EBITDA of 76.20, while Titan Biotech is deemed very expensive with a P/E of 53.19 and EV/EBITDA of 43.38. Other companies such as Stallion India and Jyoti Resins also trade at higher multiples, reinforcing Alufluoride’s relative value proposition.
Conversely, some peers like I G Petrochems and TGV Sraac are rated very attractive or attractive, but these companies often have different operational profiles or financial metrics, such as loss-making status or lower P/E ratios. Alufluoride’s combination of solid profitability and reasonable valuation places it in a unique position within this competitive landscape.
While markets shift, this one's charging ahead! This Micro Cap from Aquaculture shows the strongest momentum signals in current conditions. Don't miss out on this ride!
- - Strongest current momentum
- - Market-cycle outperformer
- - Aquaculture sector strength
Financial Performance Supports Valuation
Alufluoride’s return on capital employed (ROCE) is a robust 27.59%, while its return on equity (ROE) stands at 16.78%. These figures indicate efficient capital utilisation and healthy profitability, which justify the company’s valuation upgrade to attractive. The dividend yield, though modest at 0.74%, adds a small income component to the investment case.
Enterprise value to capital employed (EV/CE) at 3.06 and EV to sales at 1.45 further highlight the company’s operational efficiency and reasonable market pricing relative to its sales and capital base. The PEG ratio is reported as zero, which may indicate either a lack of consensus on earnings growth or a conservative estimate, but it does not detract from the overall valuation appeal.
Stock Price and Market Performance Context
Alufluoride’s current share price is ₹408.10, down 2.60% on the day from a previous close of ₹419.00. The stock has traded within a 52-week range of ₹375.50 to ₹494.00, indicating some volatility but also a capacity for upside. Today’s intraday range between ₹396.00 and ₹427.75 reflects active trading interest.
In terms of returns, the stock has underperformed the Sensex over the short term, with a one-week return of -3.57% compared to the Sensex’s -2.66%, and a one-month return of -10.40% versus the Sensex’s -9.34%. However, on a year-to-date basis, Alufluoride has outperformed the benchmark, declining only 4.52% while the Sensex fell 11.40%. Over longer horizons, the stock has delivered impressive gains, with a three-year return of 34.09% versus the Sensex’s 31.00%, a five-year return of 61.56% compared to 49.91%, and a remarkable ten-year return of 2014.51% against the Sensex’s 205.90%.
Market Capitalisation and Sector Positioning
As a micro-cap entity, Alufluoride operates in a niche segment of the commodity chemicals sector. Its market capitalisation grade reflects this status, which often entails higher volatility but also greater potential for outsized returns. The company’s valuation upgrade to attractive suggests that investors may be recognising its growth potential and operational strengths despite the inherent risks associated with smaller capitalisation stocks.
Holding Alufluoride Ltd from Commodity Chemicals? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Investment Considerations and Outlook
While Alufluoride’s valuation metrics have improved, investors should weigh the company’s micro-cap status and sector-specific risks. The commodity chemicals industry is subject to cyclical demand fluctuations, raw material price volatility, and regulatory changes, all of which can impact earnings stability.
Nonetheless, the company’s strong ROCE and ROE, combined with its attractive P/E and P/BV ratios, suggest that it is well-positioned to capitalise on favourable market conditions. The downgrade from Buy to Hold by MarketsMOJO reflects a prudent approach, signalling that while the stock is attractively priced, investors should monitor market developments and company performance closely.
Historical Valuation Context
Historically, Alufluoride’s valuation hovered around fair levels, but the recent shift to attractive indicates a relative undervaluation compared to its own past multiples and sector averages. This change may be driven by recent price corrections and improved earnings visibility, making the stock more appealing to value-oriented investors.
Given the stock’s long-term outperformance relative to the Sensex, the current valuation adjustment could represent a strategic buying opportunity for investors seeking exposure to the commodity chemicals sector with a micro-cap growth tilt.
Summary
Alufluoride Ltd’s valuation parameters have shifted favourably, with P/E and P/BV ratios now reflecting an attractive price point relative to peers and historical benchmarks. Despite a recent downgrade to Hold, the company’s strong profitability metrics and long-term return track record support a cautiously optimistic outlook. Investors should consider the stock’s micro-cap risks alongside its valuation appeal when making portfolio decisions.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
